460 related articles for article (PubMed ID: 23612465)
1. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
[TBL] [Abstract][Full Text] [Related]
2. Screening-detected lung cancers: is systematic nodal dissection always essential?
Veronesi G; Maisonneuve P; Pelosi G; Casiraghi M; Agoglia BG; Borri A; Travaini LL; Bellomi M; Rampinelli C; Brambilla D; Bertolotti R; Spaggiari L
J Thorac Oncol; 2011 Mar; 6(3):525-30. PubMed ID: 21289523
[TBL] [Abstract][Full Text] [Related]
3. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Lopes Pegna A; Picozzi G; Mascalchi M; Maria Carozzi F; Carrozzi L; Comin C; Spinelli C; Falaschi F; Grazzini M; Innocenti F; Ronchi C; Paci E;
Lung Cancer; 2009 Apr; 64(1):34-40. PubMed ID: 18723240
[TBL] [Abstract][Full Text] [Related]
4. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT.
Mascalchi M; Mazzoni LN; Falchini M; Belli G; Picozzi G; Merlini V; Vella A; Diciotti S; Falaschi F; Lopes Pegna A; Paci E
Br J Radiol; 2012 Aug; 85(1016):1134-9. PubMed ID: 21976631
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model.
Veronesi G; Maisonneuve P; Rampinelli C; Bertolotti R; Petrella F; Spaggiari L; Bellomi M
Lung Cancer; 2013 Dec; 82(3):426-30. PubMed ID: 24099665
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
[TBL] [Abstract][Full Text] [Related]
7. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
8. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
9. Initial LDCT appearance of incident lung cancers in the ITALUNG trial.
Mascalchi M; Picozzi G; Falchini M; Vella A; Diciotti S; Carrozzi L; Pegna AL; Falaschi F
Eur J Radiol; 2014 Nov; 83(11):2080-6. PubMed ID: 25174775
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
11. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
[TBL] [Abstract][Full Text] [Related]
12. The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
van't Westeinde SC; de Koning HJ; Thunnissen FB; Oudkerk M; Groen HJ; Lammers JW; Weenink C; Vernhout R; Nackaerts K; Mali W; van Klaveren RJ
J Thorac Oncol; 2011 Oct; 6(10):1704-12. PubMed ID: 21876458
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
14. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Chest; 2006 Dec; 130(6):1791-5. PubMed ID: 17166998
[TBL] [Abstract][Full Text] [Related]
15. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.
Rzyman W; Jelitto-Gorska M; Dziedzic R; Biadacz I; Ksiazek J; Chwirot P; Marjanski T
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):969-73. PubMed ID: 24008181
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the role of FDG-PET/CT in lung cancer management.
Al-Jahdali H; Khan AN; Loutfi S; Al-Harbi AS
J Infect Public Health; 2012 Dec; 5 Suppl 1():S35-40. PubMed ID: 23244185
[TBL] [Abstract][Full Text] [Related]
19. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
[TBL] [Abstract][Full Text] [Related]
20. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
Casiraghi M; Travaini LL; Maisonneuve P; Tessitore A; Brambilla D; Agoglia BG; Guarize J; Spaggiari L
Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
